Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
04.01. | Sigyn Therapeutics, Inc.: Sigyn Therapeutics Releases Letter to Shareholders | 638 | GlobeNewswire (Europe) | SAN DIEGO, CA, Jan. 04, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), a development-stage medical technology company, today announced... ► Artikel lesen | |
04.01. | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results | 322 | GlobeNewswire (Europe) | SAN RAFAEL, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the "Company"), an industry leader in exoskeleton technology for medical and industrial use, today... ► Artikel lesen | |
04.01. | Pacira BioSciences: Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues | 591 | GlobeNewswire (Europe) | TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today... ► Artikel lesen | |
04.01. | Telix Pharmaceuticals Limited: Telix Announces Planned Registered Public Offering and Listing in the United States | 297 | GlobeNewswire (Europe) | MELBOURNE, Australia, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX, "Telix" or the "Company") today announces that it is considering an initial public offering ("IPO")... ► Artikel lesen | |
04.01. | Axogen, Inc.: Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023 | 418 | GlobeNewswire (Europe) | ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries... ► Artikel lesen | |
04.01. | Eledon Pharmaceuticals, Inc.: Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook | 514 | GlobeNewswire (Europe) | Reported updated data from ongoing Phase 1b trial in kidney transplantation demonstrating tegoprubart treatment successfully prevented kidney transplant rejection and was generally safe and well-tolerated... ► Artikel lesen | |
04.01. | Axogen, Inc.: Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025 | 322 | GlobeNewswire (Europe) | ALACHUA and TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today... ► Artikel lesen | |
04.01. | REVIV3 Procare Company Reports Record Second Quarter Fiscal Year 2024 Financial Results | 412 | GlobeNewswire (Europe) | Net Sales (revenue) increased 25.1% to a record $8.4 million for the second quarter ended November 30, 2023, as compared to the prior year period.Gross Profit (as a percentage of Net Sales) was 74.3%... ► Artikel lesen | |
04.01. | Kernel Group Holdings, Inc. Confirms Funding to Extend Period to Consummate Initial Business Combination | 89 | GlobeNewswire (Europe) | New York, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Kernel Group Holdings, Inc. (NASDAQ: KRNLU, KRNL, KRNLW) ("KRNL" or the "Company"), a special purpose acquisition company, announced today it caused to... ► Artikel lesen | |
04.01. | Controladora Vuela Compañía de Aviación, S.A.B. de C.V.: Volaris Reports December 2023 Traffic Results: 85% Load Factor | 301 | GlobeNewswire (Europe) | MEXICO CITY, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS and BMV: VOLAR) ("Volaris" or "the Company"), the ultra-low-cost carrier (ULCC) serving... ► Artikel lesen | |
04.01. | Asensus Surgical, Inc.: Asensus Surgical Completes In Vivo Surgeon Lab for LUNA Surgical Robotic System | 1.831 | GlobeNewswire (Europe) | RESEARCH TRIANGLE PARK, N.C., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the... ► Artikel lesen | |
04.01. | Costco Wholesale Corporation Reports December Sales Results | 200 | GlobeNewswire (Europe) | ISSAQUAH, Wash., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation ("Costco" or the "Company") (Nasdaq: COST) today reported net sales of $26.15 billion for the retail month of December... ► Artikel lesen | |
04.01. | Allogene Therapeutics and Foresight Diagnostics Announce Partnership to Develop MRD-based In-Vitro Diagnostic for Use in ALPHA3, the First Pivotal Trial for Frontline Consolidation in Large B-Cell Lympho | 579 | GlobeNewswire (Europe) | Partnership Will Utilize Foresight's Ultra-Sensitive MRD Technology to Identify Patients for Enrollment in Allogene's ALPHA3 Trial SAN FRANCISCO and BOULDER, Colo., Jan. 04, 2024 (GLOBE NEWSWIRE) --... ► Artikel lesen | |
04.01. | Candelaria Mining Corp.: Candelaria Announces Change in Chief Financial Officer | 237 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Candelaria Mining Corp. (TSX-V: CAND, OTC PINK: CDELF) (the "Company") announces, effective January 1, 2024, Mr. Sam Wong has resigned... ► Artikel lesen | |
04.01. | CTO Realty Growth, Inc.: CTO Realty Growth Announces 2023 Transaction and Leasing Activity and Provides Share Repurchase Update | 372 | GlobeNewswire (Europe) | WINTER PARK, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- CTO Realty Growth, Inc. (NYSE: CTO) (the "Company" or "CTO") today announced its 2023 investment, disposition and leasing activities and provided... ► Artikel lesen | |
04.01. | Alpine Income Property Trust Announces 2023 Transaction Activity and Provides Corporate Update | 138 | GlobeNewswire (Europe) | WINTER PARK, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the "Company") today announced its 2023 investment and disposition activities and provided a corporate... ► Artikel lesen | |
04.01. | Lumos Pharma, Inc.: Lumos Pharma Promotes Pisit "Duke" Pitukcheewanont, MD to Chief Medical Officer | 241 | GlobeNewswire (Europe) | AUSTIN, Texas, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a late-stage biopharmaceutical company focused on therapeutics for rare diseases, has promoted Pisit "Duke" Pitukcheewanont... ► Artikel lesen | |
04.01. | Werewolf Therapeutics, Inc.: Werewolf Therapeutics Appoints Michael Atkins, M.D., to its Board of Directors | 242 | GlobeNewswire (Europe) | WATERTOWN, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the "Company" or "Werewolf") (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of... ► Artikel lesen | |
04.01. | Mineralys Therapeutics, Inc.: Mineralys Therapeutics Appoints Minji Kim, Ph.D. as Chief Business Officer | 249 | GlobeNewswire (Europe) | RADNOR, Pa., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic... ► Artikel lesen | |
04.01. | Allogene Therapeutics, Inc.: Allogene Therapeutics Announces 2024 Platform Vision to Redefine the Future of CAR T Led by ALPHA3, the Industry's First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma | 239 | GlobeNewswire (Europe) | Four Core Programs Leverage Unique Attributes in Product Development and Trial Design to Demonstrate the Unmatched Potential of an Allogeneic CAR T Large B-Cell Lymphoma (LBCL): Groundbreaking ALPHA3... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 1.682 |
NEL | 1.667 |
SUPER MICRO COMPUTER | 1.656 |
NVIDIA | 1.650 |
TUI | 1.484 |
BAYER | 1.336 |
RHEINMETALL | 1.000 |
RENK GROUP | 930 |
PROSIEBENSAT.1 | 912 |
VOLKSWAGEN | 735 |
AMAZON | 699 |
PALANTIR TECHNOLOGIES | 698 |
TESLA | 687 |
MICROSTRATEGY | 636 |
DEUTSCHE BANK | 585 |
PLUG POWER | 571 |
BASF | 565 |
BYD | 557 |
THYSSENKRUPP | 542 |
COMMERZBANK | 535 |
AIXTRON SE | 532 |
SAP | 507 |
MERCEDES-BENZ | 506 |
ALLIANZ | 493 |
DEUTSCHE TELEKOM | 473 |